
Maravai LifeSciences Investor Relations Material
Latest events

Q2 2025
Maravai LifeSciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Maravai LifeSciences Holdings Inc
Access all reports
Maravai LifeSciences Holdings, Inc. is a life sciences company providing products for research and development of drug therapies to enable the discovery, development, manufacture and commercialization of novel vaccines, therapeutics and diagnostic tests. The company's main offerings includes innovative and cost-effective products, technologies and services to the biopharmaceutical, vaccine and other healthcare industries. From small molecule development through to cell culture process development, Maravai offers a wide range of enzyme-linked immunoassay (ELISA) reagents for diagnostics development, safety testing and commercial production. Maravai's customers include market-leading companies - to which they sell proprietary technologies that enables rapid development of drug therapies, including antibody-based therapeutics, globally. Maravai LifeSciences Holdings, Inc. was founded in 2014 and is headquartered in San Diego, California.
Key slides for Maravai LifeSciences Holdings Inc


Q1 2025
Maravai LifeSciences Holdings Inc


Q2 2025
Maravai LifeSciences Holdings Inc
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
MRVI
Country
🇺🇸 United States